{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:45:00Z","timestamp":1766079900370,"version":"3.48.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021713","name":"University of Almeria","doi-asserted-by":"publisher","award":["P_LANZ_2023\/001"],"award-info":[{"award-number":["P_LANZ_2023\/001"]}],"id":[{"id":"10.13039\/501100021713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021713","name":"University of Almeria","doi-asserted-by":"publisher","award":["P_FORT_GRUPOS_2023\/68"],"award-info":[{"award-number":["P_FORT_GRUPOS_2023\/68"]}],"id":[{"id":"10.13039\/501100021713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.actatropica.2025.107903","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:16:40Z","timestamp":1762481800000},"page":"107903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasmodium vivax cysteine-rich protective antigen (PvCyRPA), an important element for vaccine strategies targeting P. vivax, interacts with human erythrocyte surface"],"prefix":"10.1016","volume":"272","author":[{"given":"Jos\u00e9","family":"Cebri\u00e1n-Carmona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-5693","authenticated-orcid":false,"given":"Gabriela","family":"Ar\u00e9valo-Pinz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Barreto-Santamaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E","family":"Guti\u00e9rrez-Orteg\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8747-1443","authenticated-orcid":false,"given":"Marcela","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-8035","authenticated-orcid":false,"given":"Asterio","family":"S\u00e1nchez-Mir\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n M\u00aa","family":"Mesa-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2030-6707","authenticated-orcid":false,"given":"Alejandro","family":"Molina-Miras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2785-0027","authenticated-orcid":false,"given":"Jos\u00e9 Antonio","family":"Garrido-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Alfonso","family":"Patarroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2025.107903_bib0001","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1038\/s41598-017-10025-6","article-title":"Plasmodium vivax ligand-receptor interaction: pvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes","volume":"7","author":"Arevalo-Pinzon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2025.107903_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2875-10-60","article-title":"PvRON2, a new Plasmodium vivax rhoptry neck antigen","volume":"10","author":"Arevalo-Pinzon","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2025.107903_bib0003","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pt.2017.10.009","article-title":"Advancing research models and technologies to overcome biological barriers to Plasmodium vivax control","volume":"34","author":"Armistead","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0004","doi-asserted-by":"crossref","first-page":"eabo6646","DOI":"10.1126\/scitranslmed.abo6646","article-title":"The RTS,S malaria vaccine: current impact and foundation for the future","volume":"14","author":"Beeson","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actatropica.2025.107903_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12936-018-2456-5","article-title":"Plasmodium vivax in vitro continuous culture: the spoke in the wheel","volume":"17","author":"Bermudez","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2025.107903_bib0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cyto.a.20152","article-title":"Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging","volume":"66","author":"Bratosin","year":"2005","journal-title":"Cytom. A"},{"key":"10.1016\/j.actatropica.2025.107903_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/cpps.47","article-title":"Overview of the Baculovirus Expression System","volume":"91","author":"Chambers","year":"2018","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.actatropica.2025.107903_bib0008","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.180.2.497","article-title":"Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion","volume":"180","author":"Chitnis","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2025.107903_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002401","article-title":"The role of animal models for research on severe malaria","volume":"8","author":"Craig","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2025.107903_bib0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10606","article-title":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum","volume":"480","author":"Crosnier","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2025.107903_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114012","article-title":"The essential malaria protein PfCyRPA targets glycans to invade erythrocytes","volume":"43","author":"Day","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.actatropica.2025.107903_bib0012","article-title":"Band 3-mediated","volume":"12","author":"De Meulenaere","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0013","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1073\/pnas.88.9.4030","article-title":"Primary structure of the merozoite surface antigen 1 of plasmodium vivax reveals sequences conserved between different Plasmodium species","volume":"88","author":"del Portillo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.actatropica.2025.107903_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg0465","article-title":"Structure of the merozoite surface protein 1 from","volume":"7","author":"Dijkman","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actatropica.2025.107903_bib0015","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.4049\/jimmunol.1103177","article-title":"Passive immunoprotection of plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen","volume":"188","author":"Dreyer","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0016","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20383","article-title":"Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody","volume":"6","author":"Favuzza","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.actatropica.2025.107903_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004639","article-title":"An antibody screen of a plasmodium vivax antigen library identifies novel merozoite proteins associated with clinical protection","volume":"10","author":"Franca","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107903_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000104","article-title":"Antibodies targeting the PfRH1 binding domain inhibit invasion of plasmodium falciparum merozoites","volume":"4","author":"Gao","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2025.107903_bib0019","unstructured":"Geneva: World Health Organization, 2017. World Malaria Report."},{"key":"10.1016\/j.actatropica.2025.107903_bib0020","unstructured":"Geneva: World Health Organization, 2024. World malaria report 2024: addressing inequity in the global malaria response."},{"issue":"188\u2013190","key":"10.1016\/j.actatropica.2025.107903_bib0021","first-page":"167","article-title":"ANTHEPROT: an interactive graphics software for analyzing protein structures from sequences","volume":"9","author":"Geourjon","year":"1991","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.actatropica.2025.107903_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/genes12010029","article-title":"Plasmodium vivax cysteine-rich protective antigen polymorphism at exon-1 shows recombination and signatures of balancing selection","volume":"12","author":"Gonzalez-Ceron","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.actatropica.2025.107903_bib0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.aan1078","article-title":"Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax","volume":"359","author":"Gruszczyk","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2025.107903_bib0024","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00179-14","article-title":"Production and preclinical evaluation of plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24","volume":"21","author":"Gupta","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13030","article-title":"Neutralising antibodies block the function of Rh5\/Ripr\/CyRPA complex during invasion of plasmodium falciparum into human erythrocytes","volume":"21","author":"Healer","year":"2019","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004264","article-title":"A library of plasmodium vivax recombinant merozoite proteins reveals new vaccine candidates and protein-protein interactions","volume":"9","author":"Hostetler","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107903_bib0027","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3389\/fimmu.2019.01254","article-title":"Functional comparison of blood-stage plasmodium falciparum malaria vaccine candidate antigens","volume":"10","author":"Illingworth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mib.2018.10.002","article-title":"Molecular and cellular interactions defining the tropism of plasmodium vivax for reticulocytes","volume":"46","author":"Kanjee","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007809","article-title":"Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites","volume":"15","author":"Knuepfer","year":"2019","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107903_bib0030","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res."},{"key":"10.1016\/j.actatropica.2025.107903_bib0031","article-title":"Complement receptor 1 is the human erythrocyte receptor for","volume":"121","author":"Lee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.actatropica.2025.107903_bib0032","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41564-021-00939-3","article-title":"Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells","volume":"6","author":"Malleret","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0033","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpara.2017.03.001","article-title":"The unhealthy attraction of Plasmodium vivax to reticulocytes expressing transferrin receptor 1 (CD71)","volume":"47","author":"Malleret","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0034","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00377-21","article-title":"Plasmodium falciparum cysteine-rich protective antigen (CyRPA) elicits detectable levels of invasion-inhibitory antibodies during natural infection in humans","volume":"90","author":"Mian","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2025.107903_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.1145213","article-title":"Erythrocyte receptors for (Plasmodium knowlesi) malaria: duffy blood group determinants","volume":"189","author":"Miller","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2025.107903_bib0036","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1016\/j.vaccine.2015.09.060","article-title":"Development of vaccines for plasmodium vivax malaria","volume":"33","author":"Mueller","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2025.107903_bib0037","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1038\/s41598-020-63611-6","article-title":"Antibodies against a short region of PfRipr inhibit plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A","volume":"10","author":"Nagaoka","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2025.107903_bib0038","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1475-2875-13-326","article-title":"A malaria vaccine candidate based on an epitope of the plasmodium falciparum RH5 protein","volume":"13","author":"Ord","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2025.107903_bib0039","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96381","article-title":"Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight."},{"key":"10.1016\/j.actatropica.2025.107903_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207244","article-title":"Blood-stage plasmodium vivax antibody dynamics in a low transmission setting: a nine year follow-up study in the Amazon region","volume":"13","author":"Pires","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2025.107903_bib0041","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.pt.2020.04.003","article-title":"The RH5-CyRPA-ripr complex as a Malaria vaccine target","volume":"36","author":"Ragotte","year":"2020","journal-title":"Trends. Parasitol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008104","article-title":"Plasmodium vivax transcriptional profiling of low input cryopreserved isolates through the intraerythrocytic development cycle","volume":"14","author":"Rangel","year":"2020","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107903_bib0043","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpara.2004.11.003","article-title":"Antibody response of naturally infected individuals to recombinant plasmodium vivax apical membrane antigen-1","volume":"35","author":"Rodrigues","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0044","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4269\/ajtmh.22-0128","article-title":"Malaria in 2022: challenges and progress","volume":"106","author":"Rosenthal","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"10","key":"10.1016\/j.actatropica.2025.107903_bib57","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1128\/JCM.37.10.3260-3264.1999","article-title":"Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain","volume":"37","author":"Rubio","year":"1999","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.actatropica.2025.107903_bib0045","doi-asserted-by":"crossref","first-page":"40169","DOI":"10.1074\/jbc.M509631200","article-title":"Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of plasmodium falciparum","volume":"280","author":"Sanders","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2025.107903_bib0046","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41564-022-01261-2","article-title":"PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","author":"Scally","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0047","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-1759(00)00323-9","article-title":"Simultaneous flow cytometric measurement of viability and lymphocyte subset proliferation","volume":"247","author":"Schmid","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.actatropica.2025.107903_bib0048","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12896-017-0400-3","article-title":"A new single-step protocol for rapid baculovirus-driven protein production in insect cells","volume":"17","author":"Scholz","year":"2017","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72671-x","article-title":"Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities","volume":"14","author":"Soares","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2025.107903_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-020-0158-9","article-title":"Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against plasmodium falciparum parasites in preclinical in vitro and in vivo models","volume":"5","author":"Tamborrini","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.actatropica.2025.107903_bib0051","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12936-023-04638-8","article-title":"The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals","volume":"22","author":"Tamborrini","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2025.107903_bib0052","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpara.2016.09.006","article-title":"Plasmodium vivax vaccine research - we've only just begun","volume":"47","author":"Tham","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2025.107903_bib0053","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-med-022411-192402","article-title":"Vaccines for malaria: how close are we?","volume":"63","author":"Thera","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.actatropica.2025.107903_bib0054","unstructured":"VaccinesWork, 13 April 2023. Five things you need to know about the new R21 malaria vaccine."},{"key":"10.1016\/j.actatropica.2025.107903_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4269\/ajtmh.2005.73.16","article-title":"Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit","volume":"73","author":"Valderrama-Aguirre","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2025.107903_bib0056","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chom.2016.06.004","article-title":"Essential role of the PfRh5\/PfRipr\/CyRPA complex during plasmodium falciparum invasion of erythrocytes","volume":"20","author":"Volz","year":"2016","journal-title":"Cell Host. Microbe"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X25003729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X25003729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:41:23Z","timestamp":1766079683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X25003729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0001706X25003729"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2025.107903","relation":{},"ISSN":["0001-706X"],"issn-type":[{"type":"print","value":"0001-706X"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium vivax cysteine-rich protective antigen (PvCyRPA), an important element for vaccine strategies targeting P. vivax, interacts with human erythrocyte surface","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2025.107903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 University of Almeria. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107903"}}